In one study, transgenic mice expressing constitutively active NIK showed a significant increase in osteoclast formation and increased bone erosion around the joints of the mice, suggesting that targeting NIK may also improve bone loss associated with RA [59]. This evidence concerns the gene MAP3K14 and rheumatoid arthritis.